Dinno F. Mendiola
Papers
8
Total Citations
59
H-Index
5
About
Dr. Dinno F. Mendiola is a leading urologic oncologist whose research focuses on the surgical and oncological management of upper tract urothelial carcinoma (UTUC). As a key contributor to the ROBUUST 2.0 collaborative group, Dr. Mendiola has driven landmark studies analyzing robot-assisted nephroureterectomy (RANU) outcomes in over 1,100 patients, demonstrating the procedure's safety and mid-term oncological efficacy. Their work has critically evaluated the impact of bladder cuff excision technique, the prognostic role of diagnostic ureteroscopy, and the utility of neoadjuvant chemotherapy for locally advanced disease. Dr. Mendiola has also developed a pretreatment nomogram to predict muscle invasion in high-risk UTUC, a tool that directly informs treatment selection. Their comparative analysis of single-dose intravesical gemcitabine versus mitomycin C after RNU provides vital evidence for postoperative chemoprophylaxis. With over 50 citations across their most-cited papers published in 2024-2025, Dr. Mendiola's contributions are shaping contemporary UTUC management, particularly through large-scale, multi-institutional data that bridge surgical technique, perioperative therapy, and personalized risk stratification.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8